Navigation Links
Chemir Announces New Custom Synthesis Laboratory
Date:2/14/2013

St. Louis, Missouri (PRWEB) February 14, 2013

Chemir is proud to announce the opening of its new chemical synthesis laboratory. The recently renovated space expands the company’s capability to synthesize analytical standards and pharmaceutical intermediates, as well as provide process development and litigation support.

The new lab boosts the efficiency of Chemir’s team of Ph.D., M.S. and B.S. synthetic chemists, as they provide organic synthesis of compounds at the milligram to kilogram scale. The dedicated laboratory space, designed by the chemists, contains new hoods, new countertops, and updated utilities. The newly installed hoods offer greater volume and expanded utilities, expanding the range of possible reactions. The renovation is part of an extensive building improvement plan for Chemir in 2013.

The expanded organic synthesis lab also reflects a greater demand for these services to support legal challenges, including patent prosecution and infringement defense.

“We’ve worked on legal synthesis projects for a variety of cases and industries,” says Dr. Albert Lee, Senior Manager of Custom Synthesis. “For example, we supported a patent prosecution case by performing synthesis based on technology from the early 1990s. We’ve also supported infringement defense issues by synthesizing a necessary analytical standard when the opposing side was uncooperative and would not provide it.”

Chemir’s custom synthesis team was previously known as IQsynthesis and Gateway Chemical Technology. Established in 1995, the group moved to the Chemir location in 2010 and assists the pharmaceutical, agrichemical and specialty chemical industries in the early phase production of molecules for research and development. The group also provides custom synthesis services for litigation support.

About Chemir –A Division of Evans Analytical Group
Chemir provides scientific solutions with analytical services, product development and litigation support services. Since 1959 this independent laboratory has solved thousands of issues involving deformulation (reverse engineering), contaminant and impurity identification, failure analysis, analytical method development, product development, custom synthesis, patent, intellectual property, and other legal challenges for over 7000 clients. The scientific staff of 35, including 8 Ph.D. level chemists, uses state-of-the-art analytical instrumentation and expert interpretations to assist such industries as polymers, plastics, medical devices, pharmaceuticals, packaging, coatings, food and beverages, personal care products, consumer products, specialty chemicals, industrial products and more. For more information, visit http://www.chemir.com.

Read the full story at http://www.prweb.com/releases/Synthesis/Laboratory/prweb10431173.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
5. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
6. WuXi PharmaTech Announces Third-Quarter 2011 Results
7. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
8. Spherix Announces Third Quarter Financial Results
9. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
10. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
11. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... CAMBRIDGE, Mass. , Jan. 21, 2017   ... of novel compounds designed to target cancer stemness pathways, ... lead investigational compound, napabucasin, at the 2017 American Society ... San Francisco . In ... administered investigational agent designed to inhibit cancer stemness pathways ...
(Date:1/20/2017)... , January 20, 2017 ... market conditions have influenced the most recent performances of ... Inc. (NASDAQ: RGLS ), Abeona Therapeutics Inc. ... TBPH ), and Sage Therapeutics Inc. (NASDAQ: ... report by Grand View Research, global Biotech market size is expected ...
(Date:1/20/2017)... , January 20, 2017 ... cancer is one of leading causes of death worldwide. ... Although the number of cancer related deaths increased gradually ... Rising in incidence rate of various cancers continues to ... a research report by Global Market Insights, Inc. cancer ...
(Date:1/19/2017)... -- Research and Markets has announced the addition of ... Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" report ... ... projected to reach $15,737 million by 2022 from $6,521 in 2015, ... Omic technologies segment accounted for more than half of ...
Breaking Biology Technology:
(Date:1/11/2017)... 11, 2017  Michael Johnson, co-founder of Visikol Inc. a company ... has been named to the elite "Forbes 30 Under 30" list ... 600 people in 20 fields nationwide to be recognized as a ... applicants were selected. ... He is currently a PhD candidate at Rutgers University. ...
(Date:1/4/2017)...  CES 2017 – Valencell , the leading ... the launch of two new versions of its ... sensor modules that incorporate the best of Valencell,s ... The two new designs include Benchmark BE2.0, a ... Benchmark BW2.0, a 2-LED version of its original ...
(Date:12/20/2016)... N.C. and GENEVA, Dec, 20, 2016 /PRNewswire/ ... biometric data sensor technology, and STMicroelectronics ... the spectrum of electronics applications, announced today the ... development kit for biometric wearables that includes ST,s ... with Valencell,s Benchmark™ biometric sensor system. ...
Breaking Biology News(10 mins):